ARCHIVES

Tracor Lands Second Biggest NCI Contract-$6.6 Million To Manage Commercial Labs’ Portion Of Bioassay Program

This article is from The Cancer Letter archive.

Vol. 01 No. 11 | April 19, 1974

Download PDF Visit The Full Archive

Related Articles

Inspector General’s chronology Of Events In Gallo Research

July 1, 1994

Kyprolis Demonstrates Overall Response Following FDA Accelerated Approval

August 31, 2012

Research Teams Win Honors For Cancer Immunotherapy Work

October 15, 2010

DePinho Explains Tenure Decision,Professors Dispute Key Details

May 30, 2014

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

March 25, 2011

New Regimens May Benefit Multiple Myeloma Patients

January 28, 2005